Breaking News
January 16, 2018 - Cycling does not negatively impact sexual and urinary health finds study
January 16, 2018 - Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Untreated Advanced Renal Cell Carcinoma
January 16, 2018 - Just How Often Do Patients Turn Post-Surgical Opioids Into a Habit?
January 16, 2018 - Opioid addiction – Genetics Home Reference
January 16, 2018 - Incomplete revascularization in PCI linked to higher mortality
January 16, 2018 - Machine learning algorithm uses brain scans to predict language ability in deaf children
January 16, 2018 - Penn scientists identify new therapeutic target for treatment of melanoma
January 16, 2018 - The London Clinic exhibits innovative technology to treat Parkinson’s disease at Arab Health
January 16, 2018 - Early influenza testing is critical to prevent serious complications
January 16, 2018 - Study Gets to the Core of Back Pain in Runners
January 16, 2018 - Year in Review: Ophthalmology | Medpage Today
January 16, 2018 - Marijuana Use
January 16, 2018 - Researchers create novel compound targeting melanoma cells
January 16, 2018 - FDA grants approval for first drug to treat inherited breast cancer
January 16, 2018 - Researchers develop remote-controlled mechanogenetics system to target and kill cancer cells
January 16, 2018 - Fresh, Frozen Embryos Equal in IVF
January 16, 2018 - Research shows biological clocks could improve brain cancer treatment
January 16, 2018 - Dire view from within accident and emergency wards of England and Wales
January 16, 2018 - Study reveals how devastating mitochondrial diseases strike families without any previous history
January 16, 2018 - Experts look for ways to standardize treatments for pediatric rheumatic diseases
January 16, 2018 - Teens who watch TV shows with ads likely to eat more junk food
January 16, 2018 - Aztec apocalypse found to be Salmonella outbreak
January 16, 2018 - Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Leber’s Hereditary Optic Neuropathy
January 16, 2018 - Three Ineffective Institutional Approaches to Quality Improvement in Healthcare
January 16, 2018 - New technology accelerates autism diagnosis and treatment
January 16, 2018 - Preterm babies likely to experience delays in auditory brain development, study reveals
January 16, 2018 - Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis
January 16, 2018 - Mitochondrial impairment may actually protect the brain in Parkinson’s disease, study shows
January 15, 2018 - Energy drinks can have adverse health effects on youth, study reveals
January 15, 2018 - 60° Pharmaceuticals (60P) Submits New Drug Application to US FDA for Antimalarial Drug Tafenoquine
January 15, 2018 - Wanted: ‘Breathalyzer’ for Cannabis Use
January 15, 2018 - Surfers more likely to get antibiotic resistant E. coli in their guts
January 15, 2018 - “Baby brain” a real clinical entity finds study
January 15, 2018 - Whole of Britain to be put on a diet plan come March
January 15, 2018 - Neighborhood Deprivation Linked to Heart Failure
January 15, 2018 - Omega-3 and Omega-6 fatty acid intake may affect lupus outcomes
January 15, 2018 - Scientists discover new enzyme that could reduce obesity rates
January 15, 2018 - Evidence suggests two patterns of early symptoms precede and predict later BD risk
January 15, 2018 - Harm minimization approach for smoking cessation with e-cigarettes
January 15, 2018 - Surgery or Antibiotics for Appendicitis? Here’s What Patients Chose
January 15, 2018 - ASH: Frailty Screening Tool Guides Therapy in Elderly
January 15, 2018 - Study shows video games could cut dementia risk in seniors
January 15, 2018 - Common Food Additive Promoting C. diff?
January 15, 2018 - Mild traumatic brain injury causes long-term damage in mice
January 15, 2018 - Circadian clock proteins set the pace of plant growth
January 15, 2018 - Two proteins shown to regenerate brain in Parkinson’s disease
January 15, 2018 - Jotting down tasks may ease falling asleep, study says
January 15, 2018 - Chi-Med Initiates Fruquintinib U.S. Clinical Trials
January 15, 2018 - Cell-Free DNA May Help Pinpoint Breast Ca Survival
January 15, 2018 - What goes on inside a medically supervised injection facility?
January 15, 2018 - Research provides new model to better ascertain HIV mortality rates in Zambia
January 15, 2018 - Genetic analysis can enhance outcomes of depression treatment
January 15, 2018 - Variations in bacterial strains can trigger varying immune responses, study states
January 15, 2018 - TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR
January 15, 2018 - HIV Vaccine Shows ‘Positive Signal’ in Small Study
January 15, 2018 - Researchers demonstrate RAS dimers are essential for cancer
January 15, 2018 - Groundbreaking report highlights plan to end bowel cancer
January 15, 2018 - Doc Aspires to Bring ‘Medicine the Musical’ to Off-Broadway
January 15, 2018 - Does an exploding brain network cause chronic pain?
January 15, 2018 - Researchers use novel PET tracer to assess myelin damage in mouse models of MS
January 15, 2018 - Survival strategy of mRNAs during sugar deficiency in the cell
January 15, 2018 - Hormone Therapy May Ease Depression Linked to Menopause
January 15, 2018 - Pain Sensitization Declines After Bariatric Tx in Obese Patients
January 15, 2018 - C7 nerve transfer improves function in spastic arm paralysis
January 15, 2018 - Australian kids are drinking and smoking far less than before
January 15, 2018 - Worsening of anxiety symptoms may be early indicator of Alzheimer’s disease
January 15, 2018 - Early testing for influenza symptoms can limit severe, life-threatening disease
January 15, 2018 - Exposure to estrogen-mimicking compounds may reverse effects of breast cancer treatment
January 15, 2018 - Lipids May Play Key Role in Abdominal Aneurysm
January 15, 2018 - Raw Dough’s a Raw Deal and Could Make You Sick
January 15, 2018 - Thinking about germs makes people concerned about how they look
January 15, 2018 - Pitt scientists develop new guidelines to alleviate EMS personnel fatigue
January 15, 2018 - Discovery suggests new approach for targeting most-wanted molecular culprits in cancer
January 14, 2018 - Rhizen Pharmaceuticals S.A. Receives FDA Orphan-Drug Designation for Tenalisib (RP6530) for Treatment of Peripheral T-Cell Lymphoma (PTCL)
January 14, 2018 - Adding Enzyme to Chemo Combo Improves Outcomes in Pancreatic CA
January 14, 2018 - Research suggests ways to help mentally ill in Ghana’s prayer camps
January 14, 2018 - U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer
January 14, 2018 - Availability of qualified nurses in hospitals affects patient satisfaction
January 14, 2018 - Prostate cancer’s gene-determined ‘immune landscape’ dictates tumor progression
January 14, 2018 - Online CME: Is This Your First Choice?
Book Review: Dreamland | Medpage Today

Book Review: Dreamland | Medpage Today

image_pdfDownload PDFimage_print

The Sunday San Diego Union-Tribune on Dec. 18, 2016, carried two stories related to opioid overdoses.

One was from the Associated Press, headlined “DRUG OVERDOSE DEATHS UP 33% NATIONWIDE.” According to the CDC, 30 states saw heroin and opioid overdose deaths increase and four had death rates jump more than 100%.


The second story was reprinted from The Washington Post with the title “STOCKING UP ON OVERDOSE KITS.” The fentanyl crisis was so bad in Canada, according to the Post, that funeral homes were now keeping kits on hand. Apparently there was some risk of absorption by embalmers or police officers so the kits would be there for them. They might also come in handy “in case a grieving funeral attendee overdoses during services.”

These articles brought to mind Sam Quinones’ detailed and terrifying non-fiction book published in 2015, Dreamland, The True Tale of America’s Opiate Epidemic.


Quinones lives in Southern California and started his investigation of drug abuse over five years ending in 2014 as a reporter for the Los Angeles Times. He points out that “abuse of prescription painkillers was behind 488,000 emergency room visits in 2011, almost triple the number of seven years before. Overdose deaths involving opiates rose from ten a day in 1999 to one every half hour by 2012.”

The story of the black tar heroin epidemic across the United States that began in the 1980s parallels the sweeping prescription opiate epidemic in America because the lined-up clientele was the same group. And the product, whether natural like heroin or manufactured like Purdue opiate pill, is the very same companion to all those Americans who wanted Better Living Through Chemistry. But heroin was cheaper, Quinones observed, and the opiate prescriptions had already “tenderized” those who would want heroin.

It’s a long, frightening story, moving backwards and forwards from how a small group of heroin growers in the villages of Xalisco on the west coast of Nayarit in Mexico started their business with family members and became successful in America by selling and delivering heroin like pizza to how Big Pharm discovered erroneous data to suggest that addicting narcotics were not really addicting whereupon manufacturer Purdue manipulated the data further.

The book is painstakingly, carefully, and accurately written. It is fascinating. And it is horrifying. It also requires some understanding because Quinones wrote two books at the same time: how easily the poppy grew in the high altitudes of coastal Nayarit, where rural Mexicans chose low-key family members to develop a heroin supply service for Americans, and how this all tied in with what some physicians thought should become a more generous and kindly professional pain relief package, even one that finally showed it was a mistake.

Agriculture is a hard life. Mexican heroin drivers “found selling heroin was just easier than growing sugar cane; it was more adventurous, and involved more cash.” An equally easy job for some doctors was starting program pain relief programs. Quinones quotes Andrew Kolodny, MD, an addiction specialist critical of the new opiate prescribing, as saying, “You now have an industry of pain specialists and this is their business model. They have a practice of patients who’ll never miss an appointment and who pay in cash.”

Quinones spoke to Nathaniel Katz, a pain specialist in Boston, who said his Harvard Medical School instructors told him people can’t become addicted because pain absorbs the euphoria. “It was all rubbish, we all know now,” he told Quinones. “We wanted [it] to be true.”

The Jick Letter

In 1980 the NEJM published a short letter to the editor from Hershel Jick, MD, a Boston University School of Medicine database physician, with his comment that patients in severe pain and under close observation had not become addicted to the given narcotic opiate.

Jick is still around, perplexed as to how or why colleagues turned his simple unsubstantiated brief paragraph into what became a “clear study” when physicians from Harvard and Johns Hopkins wrote a pain monograph later for the NIH. Scientific American called it “an extensive study.” The Institute for Clinical Systems Improvement described it as a “landmark report.”

It was a single paragraph.


Asked why doctors believed the Jick letter, Katz told Quinones: “The paragraph gives you relief from your inner conflict. It’s like drinking from the breast. All of a sudden the comfort washes over you.”

The Mexican black tar heroin epidemic was a somewhat similar story to the OxyContin plague because the two forms of narcotic had comparable effects and were obtained by persons of similar personalities. Drug abusers were everywhere and ready for academic medicine’s grievous errors in understanding pain and for Mexican business savvy in the drug trade.

In 1984 Purdue released the narcotic OxyContin, possibly the biggest therapeutic disaster in my lifetime (not because it didn’t work but because it did and was so addicting). Purdue claimed it was excited because it had created a delayed absorption slow release form of oxycodone such that there were only mild peaks and troughs in the blood levels; there was no euphoria to cause addiction. A New York City attorney, Paul Hanly, suing Purdue later in a class action lawsuit, claimed Purdue had created falsified, “ponied up” graphs. The details are murky. But Purdue Pharma pleaded guilty to a felony count of “misbranding” OxyContin and paid a fine of $634.5 million to prevent their executives being sent to prison.

Purdue could afford the fine. Quinones said “the decade of the 1990s was era of the blockbuster drug, the billion-dollar pill and a pharmaceutical sales force arms race was part of the excess of the time.” In 1995 there were 35,000 drug representatives and by 2005, 110,000. It was “feet on the street and a pharmaceutical wild west emerged …as salespeople stampeded into offices.” Sales quotas increased. Purdue paid out an additional 1$ million in 1996 for bonuses for oxy sales and in 2001, $40 million. Some Purdue reps made $100,000 in bonuses in one quarter.

“Purdue bonuses in certain areas had little relation to those paid at most U.S. companies but bore instead a striking similarity to the kinds of profits in the drug underworld,” Quinones wrote.

He is an experienced investigative reporter and presumably knows the best protection against slander or libel is the truth. His book calls a spade a spade, naming the physicians in this story who went to prison and those responsible for this harrowing, almost unbelievable account when doctors forgot the Hippocratic rule, “first, do no harm.” And Quinones understand that time is not the doctor’s friend: “Nothing cuts short a patient visit like a prescription pad!”

As a practicing physician during this period I had no idea of the extent of the problem. Quinones again: “A government survey found the number of people who reported using heroin in the previous year rose from 373,000 in 2007 to 620,000 in 2011. Eighty percent had used a prescription painkiller first. But all this took years to become clear.”

This might be a good place to pause and sort all this out because this is a most complicated and ugly story that starts with academic stupidity, continues with medical profession incompetence and individual physician greed.

Eric Anderson, MD, now retired, is a past president of the New Hampshire Academy of Family Physicians. He has also written five books, the last called The Man Who Cried Orange: Stories from a Doctor’s Life. He lives in San Diego.


Tagged with:

About author

Related Articles